IFSCC Henry Maso 2022 winner - Maxime Légues
presents the IFSCC webinar Wednesday 12 January 2022
The World’s First 3D Bioprinted Immune Skin Model Suitable for Screening Drugs
and Ingredients for Normal and Inflamed Skin
About the Webinar
The IFSCC Henry Maso Award is given to the best paper published in the IFSCC Magazine by an Author 40 years or younger. The winner of the 2022 award was chosen among a record-number 11 papers published by young Authors in the IFSCC Magazine in 2020 and 2021.
The winner, Maxime Légues of CTI Biotech (France) wrote "The World's First 3D Bioprinted Immune Skin Model Suitable for Screening Drugs and Ingredients for Normal and Inflamed Skin". This model mimics early or actue stages of atopic dermatitis and testing is dose-responsive, reproducible and suitable for safety and efficacy screening.
Chair of the IFSCC Henry Maso Award Committee, Dr. Frédéric Leroy, will be this webinar's Guest Scientist, leading the Question and Answer period.
Wednesday 12 January 2022 at our usual time: West Coast USA 8h = Mexico City/Chicago 10h = East Coast USA 11h = London 16h = 17h Central Europe = Tel Aviv/South Africa 18h = Singapore/HK/China/Perth 0h = Korea/Japan 1h = Melbourne 2h.
A recoding of the webinar will be posted on IFSCC.org (Publications section / Videos and Webinars).
About Maxime Légues, CTI Biotech Cell Therapy Research Institute (France)
Maxime Lègues joined CTIBiotech in 2019 as 3D Bioprinting scientific researcher, involved in the development and characterization of 3D human living tissues in the fields of skin, oncology, immunology and infectious diseases. His previous experiences in renowned research organizations in both France (CEA, CNRS) and Switzerland (Novimmune) gave him extensive knowledge on innovative projects regarding 3D organoid formation, molecular biology and drug testing for clinical trials. Since 2020, Maxime Lègues is the 3D Bioprinting Manager of CTIBiotech, leading their diverse research and scientific programmes in the field of 3D Bioprinting, and adapting capacities to a production scale for screening drugs and ingredients for both cosmetic and pharmaceutical companies.
About Dr. Frédéric Leroy, IFSCC Chair of Science and this webinar's Guest Scientist
Formerly Director of Strategic Foresight at L’Oréal’s Scientific Directorate, Dr. Leroy began his career at Elf-Aquitaine. In 1984 he joined L’Oréal’s Advanced Research department where he has produced over 40 publications, more than 20 patents, and presented 60+ oral presentations and posters. Additionally, Dr. Leroy has taught at ENSTA, Paris, ESCP-Paris Tech, and the Université Paris 6. He earned both his MSc and PhD in Analytical Chemistry at University Paris VI, and graduated from ESPCI-Paris Tech. He joined the IFSCC’s Praesidium in the fall of 2016.
About Mary Lynn Halland, IFSCC Secretariat General and Webinar Host
Mary Lynn joined the IFSCC in January 2016. almost exactly 6 years ago. As Secretariat General she reports into the Praesidium (Board of Directors), supporting each of their Committees. As the only employee of the IFSCC she is responsible for it's day-to-day operations. She enjoys bringing science to scientists around the world.
About Perry Romanowski, IFSCC Chair of Education, Webinar Moderator
Perry oversees all IFSCC Education programs, including the IFSCC Webinar Series. When not volunteering for the IFSCC or the Society of Cosmetic Chemists (USA and Canada Society) he runs Chemists Corner, an on-line educational company dedicated to helping cosmetic chemists of all levels of experience, but especially those aspiring to join, or new to, our industry.
Mary Lynn Halland, IFSCC Secretary General
Maxime Légues, CTI Biotech
Dr. Frédéric Leroy, IFSCC Chair of Science
Perry Romanowski, IFSCC Chair of Education